John joined GTCR in 2006 and became a Vice President in the Healthcare group in 2011. Prior to joining GTCR, he worked as an Analyst in the Healthcare group of Citigroup Global Markets in New York. John holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois. He currently serves as a Director of Riverchase Dermatology and Rx30 and works closely with Cedar Gate Technologies and XIFIN. He was previously involved in past GTCR investment Cole-Parmer, and previously served as a Director of past GTCR investment Correctional Healthcare Companies.